Proyectos

University of California, Davis, Irsicaixa

IrsiCaixa (coordinator), Universite d’Aix Marseille, Region Hovedstaden, Case Western Reserve University Corporation, Karolinska Institutet, Projecte dels Noms-Hispanosida Asociacion, Consorci Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Fundación Privada Instituto de Salud Global Barcelona (ISGlobal), Asphalion SL., AELIX Therapeutics, SL, Vedanta Biosciences, Inc.

IDIBAPS (coordinator of the project), eTheRNA, IrsiCaixa, AARHUS, VUB, LMI, CNB, SFU, EATG, UCM, ECRIN, SAPHALION, APHP, ZABALA, Aelix Therapeutics SL

Imperial College London, University of Oxford, INSERM-Cimi-Paris, Instituto de Investigación del Sida IrsiCaixa, Istituto Superiore di Sanità, Polymun Scientific, Immunbiologische Forschung GmbH, Fundació Clínic per a la Recerca Biomèdica (FCRB), Academisch Medisch Centrum, Commissariat à l’énergie Atomique et aux Energies Alternatives (CEA), Ospedale San Raffaele (OSR), Université Joseph Fourier, King’s College London, Karolinska Institutet, Universitätsklinikum Erlangen, Western University of Health Sciences, Nemzeti Élelmiszerlánc-biztonsági Hivatal/National Food Chain Safety Office, Ludwig Boltzmann Gesellschaft GmbH, BioNTech RNA Pharmaceuticals GmbH, Instituto de Salud Carlos III (ISCIII), International AIDS Vaccine Initiative (Stichting IAVI), The University of Melbourne, The University of New South Wales (UNSW Australia), Wellcome Trust Sanger Institute

Université Pierre et Marie Curie, Universität Regensburg, FIT Biotech Oy Ltd., Charité - Universitätsmedizin Berlin, St George’s University of London, MRC (Medical Research Council), IMPACTA, Centre National de la Recherche Scientifique, INSERM (Institut national de la santé et de la recherche médicale), Instituto Nacional de Saúde, GENEART AG, NOVAMEN